Key result
Synthetic HDL contrast agent boosts MRI enhancement of macrophage-rich plaque by ~94% in mice.
Answers are grounded in this paper and cite their sources.
Cardiovascular disease is one of the prime causes of mortality throughout the world and there is a need for targeted and effective contrast agents to allow noninvasive imaging of the cholesterol-rich atherosclerotic plaques in arteries. A new, fully synthetic, high-density lipoprotein (HDL)-mimicking MRI contrast agent is developed, which enhances macrophage-rich areas of plaque in a mouse model of atherosclerosis by 94%. Confirmation of the targeting of this nanoparticulate agent is achieved using confocal microscopy by tracking a fluorescent lipid incorporated into the nanoparticle.
No takes yet. Share an insight, caveat, or question.
Cormode et al. (2008) studied Atherosclerosis. ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent was evaluated on Enhancement of macrophage-rich areas of atherosclerotic plaque. A synthetic HDL-mimicking MRI contrast agent enhanced macrophage-rich areas of plaque by 94% in a mouse model of atherosclerosis.
Synapse has enriched 10 related papers. Consider them for comparative context: